statistiche ricercatore

statistiche per ROSSO, Chiara

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5657
AS - Asia 3822
EU - Europa 3109
SA - Sud America 229
AF - Africa 186
OC - Oceania 179
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5371
CN - Cina 2270
IT - Italia 921
DE - Germania 419
GB - Regno Unito 332
JP - Giappone 310
VN - Vietnam 234
CA - Canada 221
FR - Francia 200
TR - Turchia 194
KR - Corea 178
AU - Australia 158
PL - Polonia 157
BR - Brasile 147
ES - Italia 145
RU - Federazione Russa 134
TW - Taiwan 124
IN - India 114
RO - Romania 114
NL - Olanda 99
EG - Egitto 88
BE - Belgio 66
DK - Danimarca 65
IR - Iran 65
AT - Austria 57
GR - Grecia 53
MX - Messico 53
CZ - Repubblica Ceca 51
HK - Hong Kong 51
SE - Svezia 48
UA - Ucraina 48
ID - Indonesia 46
ZA - Sudafrica 39
CH - Svizzera 33
CL - Cile 33
MY - Malesia 33
SG - Singapore 32
PK - Pakistan 31
FI - Finlandia 30
PT - Portogallo 28
IE - Irlanda 27
IL - Israele 26
NZ - Nuova Zelanda 21
IQ - Iraq 18
TH - Thailandia 17
BH - Bahrain 16
KE - Kenya 16
NO - Norvegia 16
LT - Lituania 15
PE - Perù 14
AR - Argentina 13
HU - Ungheria 13
BG - Bulgaria 12
SA - Arabia Saudita 12
CO - Colombia 11
AE - Emirati Arabi Uniti 10
PH - Filippine 10
JO - Giordania 8
BO - Bolivia 7
ET - Etiopia 7
NG - Nigeria 7
DZ - Algeria 6
LK - Sri Lanka 6
SK - Slovacchia (Repubblica Slovacca) 6
EU - Europa 5
MA - Marocco 5
PA - Panama 5
RS - Serbia 5
EC - Ecuador 4
SI - Slovenia 4
UG - Uganda 4
MK - Macedonia 3
AM - Armenia 2
BD - Bangladesh 2
BF - Burkina Faso 2
CU - Cuba 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
LS - Lesotho 2
PS - Palestinian Territory 2
SN - Senegal 2
UZ - Uzbekistan 2
A1 - ???statistics.table.value.countryCode.A1??? 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BJ - Benin 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GH - Ghana 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
LY - Libia 1
Totale 13179
Salva come PNG Salva come JPEG
Città #
Fairfield 780
Houston 607
Woodbridge 475
Wilmington 383
Ann Arbor 377
Beijing 304
Seattle 302
Ashburn 280
Shanghai 264
Cambridge 209
Santa Cruz 198
Buffalo 190
Torino 182
Dong Ket 177
Guangzhou 169
Wuhan 141
Nanjing 113
Hangzhou 102
Pisa 101
San Diego 91
Warsaw 88
Taipei 80
Ottawa 67
University Park 67
Tokyo 66
Chongqing 63
Jinan 59
Toronto 56
Chengdu 53
Mountain View 53
Seoul 51
Istanbul 44
Milan 40
Changsha 39
Changchun 32
Rome 32
Central District 31
Norwalk 31
Duncan 30
Hefei 30
Las Vegas 30
Hanoi 29
Muizenberg 29
Zhengzhou 28
New York 25
Shenyang 25
Phoenix 24
Xian 24
Los Angeles 23
Clearwater 22
Henderson 22
Constanta 21
London 21
Samsun 21
Dallas 20
Lake Forest 20
Nanchang 20
Santiago 20
Tianjin 20
Ankara 19
Harbin 19
Lanzhou 19
Polska 19
Singapore 19
Sydney 19
Redmond 18
São Paulo 18
Vienna 18
Antwerpen 17
Fuzhou 17
Athens 15
Barcelona 15
Guiyang 15
Madrid 15
Aurora 14
Chicago 14
Hebei 14
Rennes 14
Birkenhead 13
Gent 13
Hanover 13
Munich 13
Richmond 13
Suzhou 13
Birmingham 12
Falls Church 12
Lima 12
Moscow 12
Nanning 12
Omsk 12
Atherstone 11
Atlanta 11
Bucharest 11
Copenhagen 11
Florence 11
Hamilton 11
Mexico 11
Nagoya 11
Stanford 11
Stuttgart 11
Totale 7479
Salva come PNG Salva come JPEG
Nome #
Liver cancer: Connections with obesity, fatty liver, and cirrhosis, file 327701 1645
Serum zonulin in patients with inflammatory bowel disease: a pilot study, file 522143 892
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease, file 633188 790
Physiopathology of intestinal barrier and the role of zonulin, file 521109 708
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance, file 356617 703
Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease, file 341232 584
Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders., file 332067 546
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein., file 422127 407
Fecal calprotectin: beyond intestinal organic diseases, file 521634 316
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study, file 322864 296
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study, file 386927 256
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes, file 331020 237
Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α, file 331485 233
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C, file 135590 223
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation, file 633507 215
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease, file 602576 209
Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation, file 633543 203
Diagnosis of Helicobacter pylori infection: a look into molecular aspects of urea breath test, file 521111 199
Altered metabolic profile and adipocyte insulin resistance mark severe liver fibrosis in patients with chronic liver disease, file 553468 190
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load, file 136280 176
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study, file 513274 172
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease, file 327516 168
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE, file 135792 157
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II, file 567465 156
Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients., file 20153 150
Increased hepatic glucose production and insulin resistance in subjects with non-alcoholic fatty liver disease is associated to increased plasma concentrations of glucogenic amino acids, file 315797 147
Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients., file 20451 144
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals, file 357325 136
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease, file 135582 135
IL28Bpolymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients, file 26061 135
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease, file 23738 122
Chronic HCV infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, MGUS and B-cell non-Hodgkin lymphoma., file 237666 120
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, file 357327 116
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease, file 230708 113
Non-alcoholic fatty liver disease and extra-hepatic cancers, file 322809 107
Metabolic Syndrome and Severity of Fibrosis in Nonalcoholic Fatty Liver Disease: An Age-Dependent Risk Profiling Study, file 250328 104
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C, file 323424 104
Endocrine manifestations of chronic HCV infection, file 332095 104
How to diagnose NAFLD in 2016, file 234616 100
Basic and clinical aspects of resistin, file 523137 90
Laboratory evidence of Helicobacter species infection in hepatocellular carcinoma, file 421365 89
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease?, file 691543 88
Epatocarcinoma: biomarcatori nella prevenzione, diagnosi e cura, file 271543 85
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts., file 560547 77
Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD, file 403018 75
Increased serum ferritin levels predict long-term mortality in patients with NAFLD, file 733837 69
Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation, file 548427 67
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation, file 548397 62
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis, file 484792 57
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases, file 597139 56
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report, file 635552 52
Liver fibrosis: the 2017 state of art, file 567425 50
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis, file 704506 50
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis, file 813187 50
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection, file 560990 49
Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic acid breath test, file 567390 49
Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease, file 690848 48
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma, file 665856 46
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis, file 811384 45
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease, file 544045 43
The combination of Index of NASH score and liver stiffness improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with NonAlcoholic Fatty Liver Disease., file 250323 39
Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression in patients with NAFLD, file 250332 39
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease: An international study in non-cirrhotic, biopsy-proven patients, file 547774 38
Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease, file 365339 37
Inflammatory Bowel Disease Nurse—Practical Messages, file 747030 37
Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in patients with Non Alcoholic Fatty Liver Disease independent of diabetes, hypertension and dyslipidemia, file 158552 34
The long-term impact of baseline PNPLA3 genotyping in patients with NAFLD. A longitudinal multicentre study, file 543920 33
Adipose tissue insulin resistance and inflammation, but not reduced hepatic fat oxidation, are associated to active NASH and severe fibrosis., file 649980 33
Immunological and virological markers during pegylated interferon therapy in HDV chronic hepatitis: any predictor of response?, file 649991 33
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma, file 747955 32
Chronic hepatitis B treatmen: current perspectives on Telbivudine, file 380393 31
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P, file 681378 31
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease, file 729609 31
Serum cytokeratin-19 fragments (CYFRA 21-1) for the prediction of overall survival in patients with hepatocellular carcinoma, file 649984 30
Macrophage markers do not add to prediction of liver fibrosis by transient elastography in patients with non-alcoholic fatty liver disease, file 649989 29
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation, file 234551 28
Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease, file 250317 28
Increased epicardial fat and early signs of impaired diastolic and systolic left ventricular function in non-diabetic, non-dyslipidemic, normotensive patients with Nonalcoholic Fatty Liver Disease, file 158480 26
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease, file 812957 26
Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease, file 365336 25
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, file 762526 25
Integrative hepatic transcriptome analysis identifies biomarkers of non-alcoholic steatohepatitis activity and fibrosis progression, file 543927 21
Alteration in lipid metabolism after an oral fat load in subjects with NAFLD., file 22111 19
Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Viral Response in Patients with Genotype 1 Chronic Hepatitis C, file 239295 19
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation, file 852418 19
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease, file 780298 18
Mechanisms for increased risk of diabetes in chronic liver diseases, file 814661 18
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy, file 780121 17
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review, file 884287 17
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease, file 886550 17
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study, file 780302 16
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease, file 938146 15
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease, file 876672 14
Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic acid breath test, file 364962 13
Insulin secretion is an independent predictor of hepatic ballooning in non-diabetic fatty liver disease., file 649982 13
Liver fibrosis: the 2017 state of art, file 364971 11
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II, file 370834 11
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?, file 811382 10
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study, file 365342 9
Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease, file 543916 9
Totale 13766
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13818
article - articoli 0
book - libri 0
conference - conferenze 1468
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2016/201773 0000 00 00 002449
2017/2018802 71737562 8051 7653 81676152
2018/20191302 74905052 6570 75140 92125293176
2019/20202614 182115162340 196171 204252 425206172189
2020/20213941 190267266249 311323 338319 350478375475
2021/20224952 542408357674 569402 417410 4673034030
Totale 13818
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie-Privacy
Logo CINECA  Copyright © 2022